Literature DB >> 27401741

Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.

Thomas Nyström1,2, Martin J Holzmann3,4, Björn Eliasson5, Ann-Marie Svensson6, Jeanette Kuhl7,8, Ulrik Sartipy9,10.   

Abstract

We performed a nationwide population-based cohort study to investigate the association between estimated glucose disposal rate (eGDR) and long-term survival after coronary artery bypass grafting (CABG) in patients with type 2 diabetes. All patients who underwent primary CABG in Sweden from 2006 to 2013 were identified from the SWEDEHEART register and by record linkage to the National Diabetes Register; all patients with type 2 diabetes were included and formed the study population. Patients were followed until 2013 through national registers for major adverse cardiovascular events and death from any cause. eGDR was calculated using waist circumference, hemoglobin A1c, and presence or the absence of hypertension. The association between eGDR and death was estimated using multivariable Cox regression. A total of 3256 patients were included. During a mean follow-up of 3.1 years (10,227 person-years), in total, 14 % patients died: 17 % (n = 186) in the 1st tertile (lowest eGDR), 14 % (n = 145) in the 2nd tertile, and 13 % (n = 133) in the 3rd tertile (highest eGDR). There was a significant association between eGDR and increased risk of death: adjusted hazard ratio (95 % confidence interval): 1.46 (1.12-1.90) for the 1st eGDR tertile compared to the 3rd and highest eGDR tertile. In conclusion, patients with type 2 diabetes who underwent CABG, a low eGDR, were associated with an increased risk of long-term all-cause mortality that was independent of other cardiovascular and metabolic risk factors. Insulin resistance measured by eGDR could be a useful risk marker in patients with type 2 diabetes and ischemic heart disease.

Entities:  

Keywords:  Coronary artery disease; Diabetes mellitus; Insulin resistance: coronary artery bypass graft surgery

Mesh:

Substances:

Year:  2016        PMID: 27401741     DOI: 10.1007/s00380-016-0875-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  49 in total

Review 1.  Review of 103 Swedish Healthcare Quality Registries.

Authors:  L Emilsson; B Lindahl; M Köster; M Lambe; J F Ludvigsson
Journal:  J Intern Med       Date:  2014-09-27       Impact factor: 8.989

2.  Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

3.  The validity of a diagnosis of heart failure in a hospital discharge register.

Authors:  Erik Ingelsson; Johan Arnlöv; Johan Sundström; Lars Lind
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

4.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

5.  Off-pump coronary artery bypass grafting for poorly controlled diabetic patients.

Authors:  Kaoru Matsuura; Mizuho Imamaki; Atsushi Ishida; Hitoshi Shimura; Yuriko Niitsuma; Masaru Miyazaki
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 1.520

6.  Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Kan Kajimoto; Naozumi Kubota; Naotake Yanagisawa; Atsushi Amano; Hiroyuki Daida
Journal:  Atherosclerosis       Date:  2009-05-04       Impact factor: 5.162

7.  The 2011 outcome from the Swedish Health Care Registry on Heart Disease (SWEDEHEART).

Authors:  Jan Harnek; Johan Nilsson; Orjan Friberg; Stefan James; Bo Lagerqvist; Kristina Hambraeus; Asa Cider; Lars Svennberg; Mona From Attebring; Claes Held; Per Johansson; Tomas Jernberg
Journal:  Scand Cardiovasc J       Date:  2013-06       Impact factor: 1.589

8.  Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery.

Authors:  Siamak Mohammadi; François Dagenais; Patrick Mathieu; John G Kingma; Daniel Doyle; Stephane Lopez; Richard Baillot; Jean Perron; Eric Charbonneau; Eric Dumont; Jacques Metras; Denis Desaulniers; Pierre Voisine
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

9.  The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART).

Authors:  Tomas Jernberg; Mona F Attebring; Kristina Hambraeus; Torbjorn Ivert; Stefan James; Anders Jeppsson; Bo Lagerqvist; Bertil Lindahl; Ulf Stenestrand; Lars Wallentin
Journal:  Heart       Date:  2010-08-27       Impact factor: 5.994

10.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

View more
  5 in total

1.  Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Gianpaolo Zerbini; Olga Lamacchia; Antonio Nicolucci; Giuseppe Pugliese
Journal:  BMC Med       Date:  2021-03-15       Impact factor: 8.775

2.  Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study.

Authors:  Alexander Zabala; Vladimer Darsalia; Marcus Lind; Ann-Marie Svensson; Stefan Franzén; Björn Eliasson; Cesare Patrone; Magnus Jonsson; Thomas Nyström
Journal:  Cardiovasc Diabetol       Date:  2021-10-06       Impact factor: 9.951

3.  Impact of estimated glucose disposal rate for identifying prevalent ischemic heart disease: findings from a cross-sectional study.

Authors:  Jin Xuan; Du Juan; Niu Yuyu; Ji Anjing
Journal:  BMC Cardiovasc Disord       Date:  2022-08-20       Impact factor: 2.174

4.  The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus.

Authors:  Zelin Li; Cuijuan Qi; Zhuoya Jia; Ruoxi Zhen; Lin Ren; Yujiao Jia; Shuchun Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-31       Impact factor: 3.249

5.  Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention.

Authors:  Chi Liu; Xiaoli Liu; Xiaoteng Ma; Yujing Cheng; Yan Sun; Dai Zhang; Qi Zhao; Yujie Zhou
Journal:  Diabetol Metab Syndr       Date:  2022-10-06       Impact factor: 5.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.